Home » Topics » BioWorld

BioWorld
RSS

ACQUISITION PUSHES MUREX INTO BLACK

May 22, 1992

HEMOGLOBIN AS DRUG DELIVERY VEHICLE

May 22, 1992

IMMU ANIMAL DATA VS. LYMPHOMAS

May 22, 1992

HANDICAPPING THE TNF RACE

May 22, 1992

WEDNESDAY STOCKS

May 21, 1992

BAYER'S BIG MOVE ON SEPSIS DRUG

May 21, 1992

IMMU REGAINS GROUND WITH EUROPEAN PATENT

May 21, 1992

LIDAK RAISES $8.4 MILLION FROM WARRANTS

May 21, 1992

EPIGEN PLANS CARCINOMA VACCINE

May 21, 1992

FDA APPROVAL PENDING FOR CHEMEX

May 21, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...